LabCompass

Eduardo Vilar‐Gómez

Medicine · Indiana University

Publications

144

Citations

7,105

Est. group size

Recurring co-author estimate

Active years

23

Publishing since 2003

Research summary
AI-generated

Eduardo Vilar-Gómez studies chronic liver diseases, with a focus on fatty liver disease driven by metabolic problems (recently termed MASLD, or metabolic dysfunction-associated steatotic liver disease). His work examines how factors such as body weight, type 2 diabetes, genetics, and alcohol consumption influence liver scarring (fibrosis) and disease progression, as well as the effects of diet and physical activity. He also investigates advanced liver disease outcomes like cirrhosis and liver cancer.

Fatty liver disease (MASLD/NAFLD)Liver fibrosis and progressionGenetic risk factors (e.g., PNPLA3)Alcohol and liver diseaseDiet, physical activity, and metabolic health

Publication activity has fluctuated year to year but remained substantial across the decade, averaging around nine papers per year over the last five years.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 8.8/year recently
2017: 6 publications172018: 16 publications182019: 12 publications192020: 21 publications21202021: 8 publications212022: 4 publications222023: 17 publications232024: 14 publications242025: 9 publications2526
Recent publications
Publishes in
  • Journal of Hepatology×21
  • Hepatology×12
  • Gastroenterology×11
  • Alimentary Pharmacology & Therapeutics×11
  • Clinical Gastroenterology and Hepatology×9

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile